Paper · 2026 · Open access
Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs
Zenodo (CERN European Organization for Nuclear Research) · Published 9 June 2026 · DOI 10.5281/zenodo.20616724
In brief
“Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs” is a 2026 paper by Darshan Jadhav*, Sheetal Gondkar, Khanderao Jadhav, Rishikesh Bachhav, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 1
Abstract
Poor aqueous solubility remains one of the most significant challenges in modern drug development, limiting the oral bioavailability and therapeutic efficacy of many pharmaceutical compounds. A substantial proportion of newly discovered drug molecules fall into Biopharmaceutics Classification System (BCS) Class II and Class IV categories, where dissolution becomes the rate-limiting step for systemic absorption. Conventional formulation approaches such as micronization, salt formation, and solid dispersions have been employed to enhance drug solubility; however, these methods often suffer from limitations including physical instability, recrystallization, limited drug loading, and lack of controlled release. In recent years, nanotechnology-based drug delivery systems have emerged as promising strategies to address these challenges by simultaneously enhancing solubility and enabling sustained drug release. This review discusses the biopharmaceutical challenges associated with poorly water-soluble drugs and highlights the rationale for employing nanotechnology in sustained drug delivery. Various nanocarrier systems including polymeric nanoparticles, lipid-based nanocarriers, polymeric micelles, dendrimers, nanosuspensions, nanosponges, and nanoemulsions are examined with respect to their structural characteristics and drug release behavior. The mechanisms governing sustained release from nanocarriers, such as diffusion-controlled, degradation-controlled, swelling-controlled, and stimuli-responsive processes, are also discussed. Additionally, key formulation design considerations, characterization techniques, and in-vitro and in-vivo evaluation strategies are summarized. Recent advances including smart nanocarriers, targeted nano-delivery, combination therapy, and integration with 3D printing technologies are highlighted. Finally, current challenges related to large-scale manufacturing, stability, regulatory approval, and cost-effectiveness are discussed along with future perspectives for personalized nanomedicine. Overall, nanotechnology-enabled sustained release systems offer a promising platform to improve the solubility, bioavailability, and therapeutic performance of poorly soluble drugs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bachhav, D. J. S. G. K. J. R. (2026). Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20616724
MLA 9
Bachhav, Darshan Jadhav*, Sheetal Gondkar, Khanderao Jadhav, Rishikesh. “Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.20616724.
Chicago
Bachhav, Darshan Jadhav*, Sheetal Gondkar, Khanderao Jadhav, Rishikesh. 2026. “Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20616724.
Harvard
Bachhav, D. J. S. G. K. J. R. (2026) ‘Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.20616724.
IEEE
D. J. S. G. K. J. R. Bachhav, “Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.20616724.
BibTeX
@article{bachhav2026nanotechnology,
title = {{Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs}},
author = {Bachhav, Darshan Jadhav*, Sheetal Gondkar, Khanderao Jadhav, Rishikesh},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2026},
doi = {10.5281/zenodo.20616724},
url = {https://doi.org/10.5281/zenodo.20616724}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- poorly water-soluble drugs
- sustained drug release
- nanocarriers
- oral bioavailability
- BCS Class II and IV drugs
- polymeric nanoparticles
- lipid-based nanocarriers
- polymeric micelles
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Bachhav, D. J. S. G. K. J. R. (2026). Nanotechnology-Enabled Strategies for Sustained Release of Poorly Soluble Drugs. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.20616724
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).
Who wrote this paper?
Darshan Jadhav*, Sheetal Gondkar, Khanderao Jadhav, Rishikesh Bachhav.
What is the DOI of this paper?
10.5281/zenodo.20616724. The permanent link is https://doi.org/10.5281/zenodo.20616724.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.